Home › Glioblastoma › Georgia › Atlanta
Glioblastoma clinical trials in Atlanta, GA
11 studies for Glioblastoma are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
RecruitingPhase 3
- Winship Cancer Institute at Emory University, Atlanta
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
RecruitingPhase 3
- Emory Winship Cancer Institute, Atlanta
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RecruitingPhase 1/2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Piedmont Oncology Research, Atlanta
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 1/2
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Emory University, Atlanta
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
RecruitingPhase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
RecruitingPhase 1
- Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Atlanta
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
RecruitingPhase 1/2
- Emory University Hospital/Winship Cancer Institute, Atlanta
Glioblastoma trials in other cities
- New York City, NY30 studies
- Boston, MA28 studies
- Houston, TX26 studies
- Los Angeles, CA24 studies
- Durham, NC20 studies
- San Francisco, CA17 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Miami, FL14 studies
- Columbus, OH14 studies
- Rochester, MN13 studies
- Jacksonville, FL13 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Multiple Myeloma42 studies
- Breast Cancer41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia31 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Metastatic Cancer28 studies
- Major Depressive Disorder25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.